Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000014272-23-000108
Filing Date
2023-05-03
Accepted
2023-05-03 19:35:00
Documents
3
Period of Report
2023-04-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_168315688775465.html 3  
1 FORM 3 wf-form3_168315688775465.xml 3 17128
2 EXHIBIT 24 - ADAM LENKOWSKY ex24poa.htm EX-24 598
3 EXHIBIT 24 - ADAM LENKOWSKY ex24poa001.jpg GRAPHIC 133526
  Complete submission text file 0000014272-23-000108.txt   203198
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Issuer) CIK: 0000014272 (see all company filings)

EIN.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543
Business Address
Lenkowsky Adam (Reporting) CIK: 0001975719 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-01136 | Film No.: 23885943